Metabolic dysfunction-associated steatotic liver disease in people living with HIV: mechanisms, diagnosis, and management
Ruoli Yu, Wei Xu, Jun Chen · 2026
Read Metabolic dysfunction-associated steatotic liver disease in people living with HIV: mechanisms, diagnosis, and management by Ruoli Yu, Wei Xu, Jun Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13624747.txt.
Description
Ruoli Yu, Wei Xu, and Jun Chen review fatty liver disease in people living with HIV in a 2026 paper. The metabolic liver condition is the world's commonest chronic liver disease. Its burden runs disproportionately high with HIV and keeps rising. Effective HIV therapy has changed, not removed, the risk.
The review reframes the disease around metabolic dysfunction as driver. In HIV, classic risk factors meet chronic immune activation. Persistent inflammation, therapy exposure, and gut-liver disruption interact. Steatosis and fibrosis follow from that mixture. Obesity-based screening misses cases in this population. Diagnosis and management sections synthesize current guidance. Integrated assessment should weigh metabolic, inflammatory, and drug history together. Cardiovascular risk belongs in the same review. The authors list research and care priorities for clinics. HIV liver care, they argue, needs its own playbook.
Catalog record
| CREATOR | Ruoli Yu, Wei Xu, Jun Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |